Emerging molecular predictive and prognostic factors in acute myeloid leukemia.

about

Sorafenib Dose Recommendation in Acute Myeloid Leukemia Based on Exposure-FLT3 Relationship.

P2860

Q54113908-F8B5F0D7-1882-4D03-BC68-9D4A4736F20C

P2860

Emerging molecular predictive and prognostic factors in acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q47670541

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Emerging molecular predictive and prognostic factors in acute myeloid leukemia.

@en

Emerging molecular predictive and prognostic factors in acute myeloid leukemia.

@nl

type

Item

label

Emerging molecular predictive and prognostic factors in acute myeloid leukemia.

@en

Emerging molecular predictive and prognostic factors in acute myeloid leukemia.

@nl

prefLabel

Emerging molecular predictive and prognostic factors in acute myeloid leukemia.

@en

Emerging molecular predictive and prognostic factors in acute myeloid leukemia.

@nl

P1476

Emerging molecular predictive and prognostic factors in acute myeloid leukemia.

@en

P2093

Mark J Levis

http://www.w3.org/2001/XMLSchema#string

Shannon R McCurdy

http://www.w3.org/2001/XMLSchema#string

P2860

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers

Recurring mutations found by sequencing an acute myeloid leukemia genome

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

Synthetic lethality and cancer: cohesin and PARP at the replication fork

DNMT3A Mutations in Acute Myeloid Leukemia

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.

P304

1-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2017.1393669

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29095060

http://www.w3.org/2001/XMLSchema#string

Emerging molecular predictive and prognostic factors in acute myeloid leukemia.

about

P2860

P2860

Emerging molecular predictive and prognostic factors in acute myeloid leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698